Stock Alert: Lixte Biotechnology Up 55%

(RTTNews) - Shares of Lixte Biotechnology Holdings Inc. (LIXT) are surging over 55% on Friday morning despite no stock-related news to drive the shares.

LIXT is currently trading at $5.88, up $2.11 or 55.97%, on the Nasdaq.

Lixte Biotechnology operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets.

The company's flagship product is LB-100, which the company believes has serious potential as an anti-cancer agent, whether used alone or in combination with other therapies.